Zixuan Pang Ph.D.
Chief Executive Officer
Dr. Zixuan Pang has served as a board member of EdiGene since 2017 and is currently the Chief Executive Officer of the company.
Dr. Pang has extensive experience in the biopharmaceutical industry as a Managing Director and Head of Biopharmaceutical Business at IDG Capital. He has invested in more than 20 startups and is deeply involved in their development.
Dr. Pang holds a dual bachelor's degree in Biology and International Politics from Peking University and a PhD in Biochemistry from Johns Hopkins University School of Medicine.